Related Experiment Videos
Pulmonary vasculitis in behcet disease: a cumulative analysis
Oguz Uzun1, Tekin Akpolat, Levent Erkan
1Department of Pilmonary Medicine, Faculty of Medicine, Ondokuz Mayis University, Tip Fak, Göğüs Hst. ABD 55139, Kurupelit-Samsun, Turkey. oguzuzun@omu.edu.tr
Chest
|June 11, 2005
Summary
Pulmonary vascular issues, including aneurysms, are common in Behçet disease (BD). Early diagnosis and immunosuppression are crucial, as anticoagulation can be fatal.
Area of Science:
- Rheumatology
- Pulmonology
- Vascular Medicine
Background:
- Behçet disease (BD) is a multisystemic inflammatory disorder.
- Pulmonary involvement in BD, though less common, can be severe and life-threatening.
- Understanding the spectrum of pulmonary manifestations is critical for timely diagnosis and management.
Purpose of the Study:
- To determine the frequency of pulmonary problems in Behçet disease.
- To delineate the clinical characteristics, prognosis, and treatment of pulmonary BD.
- To review and synthesize data from previously published cases.
Main Methods:
- A comprehensive literature review was conducted.
- 159 articles concerning pulmonary disease in BD were analyzed.
- Data from 585 cases with 598 pulmonary problems were cumulated.
Main Results:
- Pulmonary artery aneurysms (PAAs) are the most frequent pulmonary lesion in BD, often presenting with hemoptysis.
- Pulmonary vascular lesions and radiologic abnormalities are principal findings.
- Extrapulmonary venous thrombi or thrombophlebitis occurred in 78% of patients with PAAs.
Conclusions:
- Pulmonary vasculitis, leading to thrombosis, infarction, hemorrhage, and PAA, underlies most pulmonary disorders in BD.
- Close follow-up of patients with nonspecific radiologic abnormalities is essential for early detection of vascular lesions.
- Immunosuppression is the primary treatment; mistaking pulmonary vasculitis for thromboembolic disease and initiating anticoagulation can be fatal.